We function as a platform for the dissemination of therapeutics
in various areas through active R&D activities, leveraging our
core R&D capabilities.
Increase value by licensing out the results of our active R&D
activities to the right partners.
Conversely, we increase value by buying the rights to outputs
that we believe are of great value.
strategy 페이지
Our strategy
Gradual
growth
and
expansion
ATGC is pursuing step-by-step growth, moving beyond biosimilar products to biobetters and new drugs based on its own original technology.
ATGC has established a global business chain
through collaboration with reliable partners, focusing
the company’s resources onthe R&D sector and ensuring
efficient drug approvals and market entry.
OPEN
INNOVATION
ConnectingTechnologies,
a LeapintoInnovation
-
Production of products
commissioned by ATGC -
GMP certification
and audits -
Deliver products that meet
global market-specific standards
To efficiently distribute the medicines created through our R&D
production through partnerships.
By utilizing trusted partners, we can secure the right GMP
certification for each sales target and optimize the transportation
of the produced medicines.
Through these partnerships, we are able to free ourselves from
many of the risks associated with internalizing manufacturing facilities.
production through partnerships.
By utilizing trusted partners, we can secure the right GMP
certification for each sales target and optimize the transportation
of the produced medicines.
Through these partnerships, we are able to free ourselves from
many of the risks associated with internalizing manufacturing facilities.
-
Product sales and
marketing -
Collaborate on regulatory
responses by target market -
Create and execute a sales strategy for your local market
Global sales partners are dedicated to the
distribution and sale of medicines produced through
contract manufacturing.
They distribute our medically and commercially valuable
products around the world to get them to those who need them.
sometimes going beyond sales and working with us
to ensure that we respond appropriately to regulatory
requirements in the regions where they are sold.
distribution and sale of medicines produced through
contract manufacturing.
They distribute our medically and commercially valuable
products around the world to get them to those who need them.
sometimes going beyond sales and working with us
to ensure that we respond appropriately to regulatory
requirements in the regions where they are sold.
The Competitive Advantage
Provided by the Open innovation strategy
- 01
- Reduction of capital investment
costs and time
- 02
- Resolution of equipment
certification uncertainties
- 03
- Flexible response to
environmental changes
- 04
- Efficient distribution utilizing
local distribution networks
- 05
- Establishing a virtuous cycle
through a global value chain
Partnership
- Overview
-
ATGC utilizes partnerships with trusted local companies to
efficiently bring innovative therapeutics to the global market.
Innovative research
optimized development
efficient dissemination
Building a global value chain through partnerships
Our
Partners
- Manufacturing Partners(CMO)
- Global Sales Partners
